531,590 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Bought by Skba Capital Management LLC

Skba Capital Management LLC acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 531,590 shares of the medical instruments supplier’s stock, valued at approximately $10,090,000. DENTSPLY SIRONA makes up 1.6% of Skba Capital Management LLC’s portfolio, making the stock its 25th largest position. Skba Capital Management LLC owned about 0.27% of DENTSPLY SIRONA as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Riverview Trust Co bought a new stake in DENTSPLY SIRONA in the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB increased its position in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares during the last quarter. UMB Bank n.a. boosted its position in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Quarry LP increased its position in shares of DENTSPLY SIRONA by 455.0% during the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock valued at $82,000 after purchasing an additional 2,489 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on XRAY. Evercore ISI restated an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Mizuho decreased their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research note on Thursday, March 13th. Barrington Research reduced their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a report on Friday, February 28th. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research note on Friday, February 28th. Finally, UBS Group reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $23.33.

DENTSPLY SIRONA Stock Down 4.5 %

Shares of NASDAQ:XRAY opened at $14.93 on Monday. The firm has a fifty day moving average price of $17.62 and a two-hundred day moving average price of $20.16. The company has a market cap of $2.97 billion, a price-to-earnings ratio of -7.21, a PEG ratio of 1.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a one year low of $14.78 and a one year high of $33.22.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.29%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is -14.07%.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company’s stock in a transaction dated Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.52% of the stock is owned by company insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.